Related Experiment Video
Updated: May 1, 2026

Osteoarthritis Pain Model Induced by Intra-Articular Injection of Mono-Iodoacetate in Rats
Published on: May 20, 2020
Sacroiliitis Following Third (Booster) Dose of Moderna SARS-CoV-2 Vaccination Treated Successfully With Sacroiliac
Nishant J Modi1, Prem P Darji1, Iman A Rabizadeh1
1Cedars Sinai Medical Center, Anesthesiology & Advanced Pain Medicine, Los Angeles, CA.
Background:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread across the world causing the coronavirus disease 2019. Due to high infectious spread, 2 messenger RNA vaccines, Pfizer-BioNTech and Moderna, were the first SARS-CoV-2 vaccines authorized in the United States.
Case Report:
We report a rare case of a 19-year-old woman who developed isolated sacroiliitis following the third (booster) dose of the Moderna vaccination.
Conclusions:
While most vaccine adverse effects are self-resolved, we describe a unique case of isolated sacroiliitis after the SARS-CoV-2 vaccination, which was then successfully treated with sacroiliac joint injection after failing medical management.
Related Concept Videos
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Endocarditis III: Medical Management
Rheumatic Heart Disease III: Medical Management

